About Biomed Realty Trust (NYSE:BMR)
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryOffice REITs
SectorN/A
SymbolNYSE:BMR
CUSIP09063H10
Phone+1-858-4859840
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins18.98%
Return on Equity3.73%
Return on Assets2.07%
Miscellaneous
EmployeesN/A
Outstanding Shares203,530,000
Biomed Realty Trust (NYSE:BMR) Frequently Asked Questions
What is Biomed Realty Trust's stock symbol?
Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."
How were Biomed Realty Trust's earnings last quarter?
Biomed Realty Trust Inc (NYSE:BMR) announced its earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.04. The real estate investment trust earned $178.01 million during the quarter, compared to analysts' expectations of $167.08 million. Biomed Realty Trust had a return on equity of 3.73% and a net margin of 18.98%. The business's revenue was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.38 earnings per share. View Biomed Realty Trust's Earnings History.
Who are some of Biomed Realty Trust's key competitors?
Some companies that are related to Biomed Realty Trust include Berkshire Hathaway (BRK.B), Berkshire Hathaway (BRK.A), Alibaba Group (BABA), JPMorgan Chase (JPM), Johnson & Johnson (JNJ), ExxonMobil (XOM), Bank of America (BAC), Royal Dutch Shell (RDS.B), Royal Dutch Shell (RDS.A), Walmart (WMT), Visa (V), Wells Fargo (WFC), Chevron (CVX), UnitedHealth Group (UNH), Pfizer (PFE), AT&T (T), The Home Depot (HD) and Taiwan Semiconductor Mfg. (TSM).
Who are Biomed Realty Trust's key executives?
Biomed Realty Trust's management team includes the folowing people:
- Greg N. Lubushkin, Chief Financial Officer (Age 62)
- James R. Berens, President of Wexford Science & Technology (Age 61)
- Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary (Age 39)
- John P. Bonanno, Executive Vice President, Leasing & Development (Age 49)
- Karen A. Sztraicher, Executive Vice President - Asset Management (Age 51)
Has Biomed Realty Trust been receiving favorable news coverage?
News coverage about BMR stock has trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Biomed Realty Trust earned a media sentiment score of 0.15 on Accern's scale. They also assigned headlines about the real estate investment trust an impact score of 47.32 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Biomed Realty Trust?
Shares of BMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Biomed Realty Trust's stock price today?
One share of BMR stock can currently be purchased for approximately $23.81.
How can I contact Biomed Realty Trust?
Biomed Realty Trust's mailing address is 17190 Bernardo Center Dr, SAN DIEGO, CA 92128-7030, United States. The real estate investment trust can be reached via phone at +1-858-4859840.
MarketBeat Community Rating for Biomed Realty Trust (BMR)
MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe BMR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Biomed Realty Trust (NYSE:BMR) Dividend Information
Biomed Realty Trust pays an annual dividend of $1.04 per share, with a dividend yield of 4.37%. BMR's most recent quarterly dividend payment was Thursday, October 15.
| Most Recent Dividend: | 10/15/2015 |
| Annual Dividend: | $1.04 |
| Dividend Yield: | 4.37% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | N/A |
Biomed Realty Trust (NYSE:BMR) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 9/16/2015 | quarterly | $0.26 | 5.35% | 9/28/2015 | 9/30/2015 | 10/15/2015 |
| 6/16/2015 | quarterly | $0.26 | 5.22% | 6/26/2015 | 6/30/2015 | 7/15/2015 |
| 3/17/2015 | quarterly | $0.26 | 4.73% | 3/27/2015 | 3/31/2015 | 4/15/2015 |
| 12/12/2014 | special | $0.30 | 4.88% | 12/18/2014 | 12/22/2014 | 12/29/2014 |
| 12/12/2014 | quarterly | $0.26 | 4.88% | 12/29/2014 | 12/31/2014 | 1/15/2015 |
| 9/16/2014 | quarterly | $0.25 | 4.73% | 9/26/2014 | 9/30/2014 | 10/15/2014 |
| 6/16/2014 | quarterly | $0.25 | 4.54% | 6/26/2014 | 6/30/2014 | 7/15/2014 |
| 3/17/2014 | quarterly | $0.25 | 4.87% | 3/27/2014 | 3/31/2014 | 4/15/2014 |
| 12/16/2013 | quarterly | $0.25 | 5.46% | 12/27/2013 | 12/31/2013 | 1/15/2014 |
| 9/16/2013 | quarterly | $0.2350 | 4.83% | 9/26/2013 | 9/30/2013 | 10/15/2013 |
| 6/17/2013 | quarterly | $0.2350 | 4.61% | 6/26/2013 | 6/28/2013 | 7/15/2013 |
| 3/18/2013 | quarterly | $0.2350 | 4.3% | 3/26/2013 | 3/28/2013 | 4/15/2013 |
| 12/14/2012 | quarterly | $0.2350 | 4.95% | 12/27/2012 | 12/31/2012 | 1/15/2013 |
(Data available from 1/1/2013 forward)
Biomed Realty Trust (NYSE:BMR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
